LEADER 02829nam  2200541Ia 450 
001 9910456351703321
005 20200520144314.0
010   $a0-309-50133-4
035   $a(CKB)110986584753068
035   $a(EBL)3375491
035   $a(SSID)ssj0000279094
035   $a(PQKBManifestationID)11210759
035   $a(PQKBTitleCode)TC0000279094
035   $a(PQKBWorkID)10258239
035   $a(PQKB)10482965
035   $a(MiAaPQ)EBC3375491
035   $a(Au-PeEL)EBL3375491
035   $a(CaPaEBR)ebr10038769
035   $a(OCoLC)923256771
035   $a(EXLCZ)99110986584753068
100   $a20000627d2000      uy             0
101 0 $aeng
135   $aur|n|---|||||
181   $ctxt
182   $cc
183   $acr
200 10$aEnding neglect$b[electronic resource] $ethe elimination of tuberculosis in the United States /$fLawrence Geiter, editor ; Committee on the Elimination of Tuberculosis in the United States, Division of Health Promotion and Disease Prevention, Institute of Medicine
210   $aWashington, D.C. $cNational Academy Press$dc2000
215   $a1 online resource (292 p.)
300   $aDescription based upon print version of record.
311   $a0-309-07028-7 
320   $aIncludes bibliographical references and index.
327   $a""Cover""; ""Front Matter""; ""Preface""; ""Acknowledgments""; ""Contents""; ""Executive Summary""; ""1 Fundamentals of Tuberculosis and Tuberculosis Control""; ""2 The Current Situation and How We Got Here""; ""3 Tuberculosis Elimination and the Changing Role of Tuberculosis Control Programs""; ""4 Advancing Toward Elimination""; ""5 Developing the Tools for Tuberculosis Elimination""; ""6 The U.S. Role in Global Tuberculosis Control""; ""7 Mobilizing for Elimination""; ""APPENDIXES""; ""APPENDIX A Statement of Task""; ""APPENDIX B Public Session Agendas""
327   $a""APPENDIX C Site Visit Summaries""""APPENDIX D Role of Public Health Laboratories in the Control of Tuberculosis""; ""APPENDIX E Estimating the Number of Tuberculosis Cases That Can Be Prevented by a Program of Screening and Preventive Therapy of Newly Arrived Immigrants to the United States from Countries with a High Rate of Tuberculosis and the Costs of the Program""; ""APPENDIX F Approval Dates for Existing and Prospects for Development of New Antituberculosis Drugs and Vaccines""; ""APPENDIX G Committee Biographies""; ""Index""
606   $aTuberculosis$zUnited States
606   $aInternal medicine
608   $aElectronic books.
615  0$aTuberculosis
615  0$aInternal medicine.
676   $a614.5/42/0973
701   $aGeiter$b Lawrence$0978903
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910456351703321
996   $aEnding neglect$92231171
997   $aUNINA